Theriva Biologics (TOVX) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.19
-2.18
-0.16
1.85

Details

Expected EPS
-0.435
Actual EPS
1.85
Surprise EPS
2.29
Surprise Percent
+525.29%

Description

Theriva Biologics (TOVX) has reported earnings of 1.85 per share for Q1 2026.

0 Comments

Share your thoughts